Botanix Pharmaceuticals (ASX:BOT) Ending Cash Position : A$18.31 Mil (As of Dec. 2023)

View and export this data going back to 1985. Start your Free Trial

What is Botanix Pharmaceuticals Ending Cash Position?

Botanix Pharmaceuticals's Ending Cash Position for the quarter that ended in Dec. 2023 was A$18.31 Mil.

Botanix Pharmaceuticals's quarterly Ending Cash Position increased from Dec. 2022 (A$8.72 Mil) to Jun. 2023 (A$10.25 Mil) and increased from Jun. 2023 (A$10.25 Mil) to Dec. 2023 (A$18.31 Mil).

Botanix Pharmaceuticals's annual Ending Cash Position declined from Jun. 2021 (A$21.56 Mil) to Jun. 2022 (A$7.29 Mil) but then increased from Jun. 2022 (A$7.29 Mil) to Jun. 2023 (A$10.25 Mil).

Botanix Pharmaceuticals Ending Cash Position Historical Data

The historical data trend for Botanix Pharmaceuticals's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Botanix Pharmaceuticals Ending Cash Position Chart

Botanix Pharmaceuticals Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Ending Cash Position

Get a 7-Day Free Trial

4.70

24.65

21.56

7.29

10.25

Botanix Pharmaceuticals Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Ending Cash Position	Get a 7-Day Free Trial															16.85	7.29	8.72	10.25	18.31

Botanix Pharmaceuticals Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Botanix Pharmaceuticals's Ending Cash Position for the fiscal year that ended in Jun. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	7.285	+	2.965
	=	10.25

Botanix Pharmaceuticals's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	10.25	+	8.063
	=	18.31

Botanix Pharmaceuticals Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Botanix Pharmaceuticals's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Botanix Pharmaceuticals (ASX:BOT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Botanix Pharmaceuticals Ltd (ASX:BOT) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

BXPHF:USA

Address

661 Newcastle Street, D2, LEEDERVILLE, WA, AUS, 6007

Website

https://www.botanixpharma.com

Botanix Pharmaceuticals Ltd is a clinical-stage cannabinoid therapeutics company. The company's focus is the development of safe and effective topical treatments for serious skin conditions. It has an exclusive license to use a proprietary drug delivery system - Permetrex for direct skin delivery of active pharmaceuticals in all skin diseases. The company's product pipeline includes BTX1503 - Moderate to Severe Acne, BTX1308 - Plaque Psoriasis, BTX1204 - Atopic Dermatitis, and BTX 1701 - Mild Acne. The majority of Revenue is Derived from Australia.

Botanix Pharmaceuticals (ASX:BOT) Headlines

No Headlines